Damaged glomeruli in proliferative pediatric lupus nephritis exhibit a C5a-C5aR1 induced fibrotic transcriptional

Sarah McCuaig1, Easton Elliott1, Seth Anderson2

  • 1Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA.

Insights

Lupus nephritis involves kidney damage, but not from interferon. Instead, complement C5a signaling drives fibrosis in damaged glomeruli, offering new therapeutic targets for this condition.

Area of Science:

  • Nephrology
  • Immunology
  • Genomics

Background:

  • Lupus nephritis (LN) is a severe complication of pediatric systemic lupus erythematosus (pSLE), leading to poor kidney outcomes and treatment side effects.
  • LN exhibits patchy glomerular damage within the same kidney, complicating understanding of injury drivers.
  • Current understanding of LN pathogenesis lacks insight into localized glomerular injury mechanisms.

Purpose of the Study:

  • To investigate microanatomic transcriptional differences between damaged and unaffected glomeruli in pSLE LN using spatial transcriptomics.
  • To identify local drivers of renal injury in lupus nephritis.
  • To explore the role of complement activation and fibrosis in LN pathogenesis.

Main Methods:

  • Spatial transcriptomic analysis of glomeruli from pSLE LN patients to compare transcriptional profiles of damaged versus unaffected areas.
  • Bulk RNA-sequencing of C5a-stimulated human monocyte-derived-macrophages.
  • Analysis of complement component 5a (C5a) and its receptor C5aR1 signaling pathways.

Main Results:

  • Glomerular damage in LN did not correlate with Type I interferon response, contrary to expectations for SLE.
  • Transcriptional analysis revealed that damage was associated with myeloid cell markers, C5AR1 (receptor for C5a), early complement components, and fibrosis genes.
  • C5a stimulation of macrophages upregulated tissue-remodeling and fibrosis pathways, which were reversed by avacopan, a C5aR1 inhibitor.
  • Genes induced by C5a were significantly elevated in damaged LN glomeruli compared to unaffected ones, establishing a link between C5a-C5aR1 signaling and early fibrosis.

Conclusions:

  • Complement C5a-C5aR1 signaling is a key driver of early fibrosis in proliferative lupus nephritis, independent of interferon response.
  • This pathway represents a potential therapeutic target for lupus nephritis and other inflammatory diseases involving complement activation.
  • The findings highlight an underappreciated link between complement activation and fibrotic processes in SLE.